• Mabcampath


Facts of Mabcampath (Alemtuzumab) ?

  • Medicine Name: Mabcampath
  • Generic Name: Alemtuzumab
  • Approval Date: 2001
  • Company Name: Genzyme Corporation
  • Available as (Form & Strength): 30 mg/1 mL single use vial

Product Description

What are the indications and usage?

MabCampath is used to treat patients with B-cell chronic lymphocytic leukaemia (B-CLL), a cancer of a type of white blood cell called B lymphocytes. MabCampath is used in patients for whom treatment combinations including fludarabine (another medicine used in leukaemia) are not appropriate. The medicine can only be obtained with a prescription.


There are no reviews yet.

Be the first to review “Mabcampath”